Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Fertigspritze und Fertigpen), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- 1 0 1 Carefarm GmbH, 2care4 ApS, Aaragon Pharma s.r.o, Abacus Medicine A/S, ACA Müller ADAG Pharma AG, B2B Medical GmbH, CC Pharma GmbH, Celltrion Healthcare Deutschland GmbH, EurimPharm Arzneimittel GmbH, Fresenius Kabi Deutschland GmbH, Gedeon Richter Pharma GmbH, kohlpharma GmbH, Medicopharm AG, Orifarm GmbH, Originalis B.V., Paranova Pack A/S, Roche Pharma AG
- Contract value
- no value published
- Bids received
- 9
- Published
- 1 Sept 2026
- Awarded
- 1 Dec 2025
- Contract start
- 1 Dec 2025
- Contract end
- 14 Dec 2026estimated
- Region
- Hamburg